Skip to main content
Figure 3 | Orphanet Journal of Rare Diseases

Figure 3

From: X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management

Figure 3

MRI of the brain (T2 (A) and FLAIR (C) images; T1 with gadolinium (B, D)) of a patient with AMN who rapidly deteriorated clinically with new symptoms of cognitive decline. On MRI extensive white matter changes were seen in the parieto-occipital white matter and corpus callosum (A), but no enhancement of the lesion after administration of gadolinium (B). A follow-up MRI about 3 months later shows progression of the white matter lesion (C) and there is now faint enhancement of the rim of the lesion after gadolinium administration (D).

Back to article page